Targeted drugs recognize specific markers, typically proteins, that help cancer cells grow and spread.
Breast cancer treatment has undergone a significant transformation, evolving from broad-spectrum chemotherapy to highly targeted therapies that address specific molecular subtypes. Today, treatment is largely guided by such as hormone receptors (ER/PR) and the human epidermal growth factor receptor 2 (HER2), which allow for a "precision medicine" approach. 1. Hormone (Endocrine) Therapies
Challenges and Opportunities in Metastatic Breast Cancer Treatments
Hormone therapies are used for cancers that are hormone receptor-positive (HR+), meaning they use estrogen or progesterone to grow. These drugs either lower hormone levels or block receptors on cancer cells.